641301240	641301240	CD	B-NP	O
|	|	NN	I-NP	O
TMH	TMH	NN	I-NP	O
|	|	NN	I-NP	O
45740634	45740634	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
6103698	6103698	CD	B-NP	O
|	|	CC	I-NP	O
1/25/2005	1/25/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/21/2005	4/21/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
ATTENDING	ATTENDING	NNP	B-NP	O
:	:	:	O	O
GOSNELL	GOSNELL	NNP	B-NP	O
,	,	,	O	O
BRICE	BRICE	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
PRELIMINARY	PRELIMINARY	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
.	.	.	O	O

PRINCIPAL	PRINCIPAL	JJ	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
Aspiration	Aspiration	NN	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
,	,	,	O	O
line	line	NN	B-NP	O
infection	infection	NN	I-NP	O
,	,	,	O	O
refractor	refractor	NN	B-NP	O
asthma	asthma	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
59-year-old	59-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
well	well	RB	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
team	team	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
COPD/asthma	COPD/asthma	NN	B-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
intubation	intubation	NN	B-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
schizoaffective	schizoaffective	JJ	B-NP	O
disorder	disorder	NN	I-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
night	night	NN	B-NP	O
sweats	sweat	NNS	I-NP	O
from	from	IN	B-PP	O
Landall	Landall	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
from	from	IN	B-PP	O
GMS	GMS	NNP	B-NP	O
to	to	TO	B-VP	O
rehab	rehab	VB	I-VP	O
on	on	IN	B-PP	O
January	January	NNP	B-NP	O
after	after	IN	B-PP	O
being	be	VBG	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	O	O
treated	treat	VBN	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
COPD	COPD	NN	I-NP	O
flare	flare	NN	I-NP	O
with	with	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
of	of	IN	B-PP	O
azithromycin	azithromycin	NN	B-NP	O
,	,	,	O	O
prednisone	prednisone	NN	B-NP	O
taper	taper	NN	I-NP	O
and	and	CC	I-NP	O
nebulizer	nebulizer	NN	I-NP	O
treatments	treatment	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
O2	O2	NN	I-NP	O
sats	sat	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
90s	90	NNS	I-NP	O
on	on	IN	B-PP	O
two	two	CD	B-NP	O
liters	liter	NNS	I-NP	O
-LRB-	-LRB-	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
O2	O2	NN	I-NP	O
requirement	requirement	NN	I-NP	O
is	be	VBZ	B-VP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Now	Now	RB	B-ADVP	O
she	she	PRP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
night	night	NN	B-NP	O
sweats	sweat	NNS	I-NP	O
and	and	CC	O	O
cough	cough	NN	B-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
productive	productive	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
chest	ch	JJS	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
,	,	,	O	O
lightheadedness	lightheadedness	NN	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
diarrhea	diarrhea	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
finished	finish	VBD	B-VP	O
a	a	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
after	after	IN	B-PP	O
an	an	DT	B-NP	O
admit	admit	NN	I-NP	O
from	from	IN	B-PP	O
July	July	NNP	B-NP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
of	of	IN	B-PP	O
May	May	NNP	B-NP	O
for	for	IN	B-PP	O
similar	similar	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
Landchi	Landchi	NNP	I-NP	O
Vier	Vier	NNP	I-NP	O
Community	Community	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
to	to	TO	B-PP	O
Townfaxt	Townfaxt	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
ED	ED	VBD	B-VP	O
with	with	IN	B-PP	O
vital	vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
were	be	VBD	B-VP	O
99.5	99.5	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
120	120	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
105/35	105/35	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
respiratory	respiratory	JJ	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
36	36	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
81	81	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
and	and	CC	O	O
86	86	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
5	5	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
received	receive	VBD	B-VP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Ativan	Ativan	NNP	B-NP	O
,	,	,	O	O
5	5	CD	B-NP	O
duonebs	duoneb	NNS	I-NP	O
,	,	,	O	O
500	500	CD	B-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
of	of	IN	B-PP	O
clindamycin	clindamycin	NN	B-NP	O
,	,	,	O	O
500	500	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
ABG	ABG	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
7.32	7.32	CD	B-NP	O
/	/	SYM	B-NP	O
82/113	82/113	CD	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
troponin	troponin	NN	I-NP	O
was	be	VBD	B-VP	O
0.13	0.13	CD	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
BNP	BNP	NN	I-NP	B-protein
was	be	VBD	B-VP	O
29	29	CD	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
required	require	VBD	B-VP	O
ICU	ICU	NN	B-NP	O
care	care	NN	I-NP	O
and	and	CC	B-PP	O
since	since	IN	B-PP	O
no	no	DT	B-NP	O
beds	bed	NNS	I-NP	O
were	be	VBD	B-VP	O
available	available	JJ	B-ADJP	O
at	at	IN	B-PP	O
Morei	Morei	NNP	B-NP	O
Horan	Horan	NNP	I-NP	O
Winblo	Winblo	NNP	I-NP	O
Health	Health	NNP	I-NP	O
Center	Center	NNP	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Ceville	Ceville	NNP	I-NP	O
Tianfaulkharb	Tianfaulkharb	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
vital	vital	JJ	I-NP	O
signs	sign	NNS	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
include	include	VBP	B-VP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
110	110	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
190/55	190/55	CD	B-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
32	32	CD	B-NP	O
and	and	CC	O	O
sats	sat	NNS	B-NP	O
87	87	CD	B-NP	O
to	to	TO	B-PP	O
89	89	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
4	4	CD	B-NP	O
liters	liter	NNS	I-NP	O
,	,	,	O	O
going	go	VBG	B-VP	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
95	95	CD	I-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
6	6	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
received	receive	VBD	B-VP	O
vancomycin	vancomycin	NN	B-NP	O
1.5	1.5	CD	I-NP	O
IV	IV	CD	I-NP	O
x1	x1	NN	I-NP	O
,	,	,	O	O
albuterol	albuterol	NN	B-NP	O
and	and	CC	I-NP	O
Atrovent	Atrovent	NN	I-NP	O
nebs	neb	NNS	I-NP	O
stack	stack	VBP	B-VP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
aspirin	aspirin	NN	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Remarkable	Remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
COPD/asthma	COPD/asthma	NN	B-NP	O
with	with	IN	B-PP	O
last	last	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
2005	2005	CD	I-NP	O
showing	show	VBG	B-VP	O
an	an	DT	B-NP	O
FVC	FVC	NN	I-NP	O
of	of	IN	B-PP	O
41	41	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
FEV1	FEV1	NN	B-NP	O
of	of	IN	B-PP	O
0.74	0.74	CD	B-NP	O
liters	liter	NNS	I-NP	O
,	,	,	O	O
33	33	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
ratio	ratio	NN	I-NP	O
of	of	IN	B-PP	O
FEV1/FVC	FEV1/FVC	NN	B-NP	O
of	of	IN	B-PP	O
83	83	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
schizoaffective	schizoaffective	JJ	B-NP	O
disorder/questionable	disorder/questionable	JJ	I-NP	O
bipolar	bipolar	NN	I-NP	O
,	,	,	O	O
GERD	GERD	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
with	with	IN	B-PP	O
EF	EF	NN	B-NP	B-protein
of	of	IN	B-PP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
an	an	DT	B-NP	O
echo	echo	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
2005	2005	CD	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
and	and	CC	I-NP	O
steroid	steroid	NN	I-NP	O
myopathy	myopathy	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Dig	Dig	NNP	B-NP	O
0.25	0.25	CD	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

Guaifenesin	Guaifenesin	NN	B-NP	O
10	10	CD	I-NP	O
ml	ml	NN	I-NP	O
q.	q.	NN	I-NP	O
4	4	CD	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
for	for	IN	B-PP	O
cough	cough	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Insulin	Insulin	NN	B-NP	O
NPH	NPH	NN	I-NP	O
56/12	56/12	CD	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Isordil	Isordil	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
t.i.d.	t.i.d.	NN	I-NP	I-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

Lactulose	Lactulose	RB	B-NP	O
15	15	CD	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Lisinopril	Lisinopril	NNP	B-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Ativan	Ativan	IN	B-PP	O
0.5	0.5	CD	B-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
6	6	CD	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
for	for	IN	B-PP	O
anxiety	anxiety	NN	B-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Milk	Milk	NNP	B-NP	O
of	of	IN	B-PP	O
Magnesia	Magnesia	NNP	B-NP	O
30	30	CD	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
constipation	constipation	NN	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Robaxin	Robaxin	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
500	500	CD	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

Nystatin	Nystatin	NN	B-NP	O
5	5	CD	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
13	13	CD	I-NP	O
.	.	.	O	O

Prednisone	Prednisone	NN	B-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

MDI	MDI	NNP	B-NP	O
Atrovent	Atrovent	NNP	I-NP	O
q.	q.	.	O	O
4	4	CD	B-NP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Risperdal	Risperdal	JJ	B-NP	B-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

16	16	CD	B-NP	O
.	.	.	O	O

Miconazole	Miconazole	NN	B-NP	O
powder	powder	NN	I-NP	O
topical	topical	JJ	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
17	17	CD	I-NP	O
.	.	.	O	O

Seroquel	Seroquel	NNP	B-NP	O
200/600	200/600	CD	I-NP	O
.	.	.	O	O

18	18	CD	B-NP	O
.	.	.	O	O

Singulair	Singulair	NNP	B-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

19	19	CD	B-NP	O
.	.	.	O	O

Vitamin	Vitamin	NN	B-NP	O
D	D	NN	I-NP	O
3-400	3-400	NN	I-NP	O
.	.	.	O	O

20	20	CD	B-NP	O
.	.	.	O	O

Trileptal	Trileptal	JJ	B-NP	O
75	75	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
21	21	CD	I-NP	O
.	.	.	O	O

Depakote	Depakote	NNP	B-NP	O
250	250	CD	I-NP	O
.	.	.	O	O

22	22	CD	B-NP	O
.	.	.	O	O

Advair	Advair	NN	B-NP	O
1	1	CD	I-NP	O
puff	puff	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
23	23	CD	I-NP	O
.	.	.	O	O

Caltrate	Caltrate	NNP	B-NP	O
Plus	Plus	NNP	I-NP	O
D.	D.	NNP	I-NP	O
24	24	CD	I-NP	O
.	.	.	O	O

Duonebs	Duoneb	NNS	B-NP	O
p.r.n.	p.r.n.	VBP	B-VP	O
25	25	CD	B-NP	O
.	.	.	O	O

?	?	.	O	O
?	?	.	O	O
_____	_____	''	O	B-protein
?	?	.	O	I-protein
?	?	.	O	I-protein
Insulin	Insulin	NNP	B-NP	I-protein
6	6	CD	I-NP	I-protein
q.a.c.	q.a.c.	NN	I-NP	O
26	26	CD	I-NP	O
.	.	.	O	O

Levalbuterol	Levalbuterol	NN	B-NP	O
1.25	1.25	CD	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
27	27	CD	I-NP	O
.	.	.	O	O

Lasix	Lasix	NNP	B-NP	O
80	80	CD	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Penicillin	Penicillin	NN	B-NP	B-protein
,	,	,	O	O
sulfa	sulfa	NN	B-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
lives	live	VBZ	B-VP	O
alone	alone	RB	B-ADVP	O
but	but	CC	O	O
has	have	VBZ	B-VP	O
husband	husband	NN	B-NP	O
who	who	WP	B-NP	O
is	be	VBZ	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

Attends	Attend	VBZ	B-VP	O
Geri-day	Geri-day	JJ	B-NP	O
program	program	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
per	per	IN	B-PP	O
week	week	NN	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
ON	ON	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
:	:	:	O	O
Heart	Heart	NN	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
105	105	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
98/64	98/64	CD	I-NP	O
.	.	.	O	O

Sat	Sat	NNP	B-NP	O
of	of	IN	B-PP	O
94	94	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
six	six	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
general	general	JJ	B-NP	O
exam	exam	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
morbidly	morbidly	RB	B-ADJP	O
obese	obese	JJ	I-ADJP	O
,	,	,	O	O
working	work	VBG	B-VP	O
to	to	TO	I-VP	O
breathe	breathe	VB	I-VP	O
,	,	,	O	O
speaking	speak	VBG	B-VP	O
in	in	IN	B-PP	O
phrases	phrase	NNS	B-NP	O
.	.	.	O	O

Wanting	Wanting	JJ	B-NP	O
water	water	NN	I-NP	O
.	.	.	O	O

Respiratory	Respiratory	JJ	B-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Tearing	Tearing	NN	B-NP	O
eyes	eye	NNS	I-NP	O
.	.	.	O	O

Sclerae	Sclerae	NNP	B-NP	O
anicteric	anicteric	JJ	I-NP	O
.	.	.	O	O

Extraocular	Extraocular	JJ	B-NP	O
muscles	muscle	NNS	I-NP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Oropharynx	Oropharynx	NNP	B-NP	O
was	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

Chest	Ch	JJS	B-ADVP	O
with	with	IN	B-PP	O
very	very	RB	B-NP	O
poor	poor	JJ	I-NP	O
air	air	NN	I-NP	O
movement	movement	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
end	end	VB	I-VP	O
expiratory	expiratory	JJ	B-NP	O
wheezes	wheeze	NNS	I-NP	O
throughout	throughout	IN	B-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
cardiovascular	cardiovascular	JJ	I-NP	O
:	:	:	O	O
JVP	JVP	NN	B-NP	B-protein
not	not	RB	O	O
visualized	visualize	VBD	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
body	body	NN	B-NP	O
habitus	habitus	NN	I-NP	O
.	.	.	O	O

Tachycardic	Tachycardic	JJ	B-ADJP	O
.	.	.	O	O

Distant	Distant	JJ	B-NP	O
heart	heart	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
was	be	VBD	B-VP	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
obese	obese	JJ	I-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
extremities	extremity	NNS	I-NP	O
:	:	:	O	O
There	There	EX	B-NP	O
was	be	VBD	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
knee	knee	NN	I-NP	O
level	level	NN	I-NP	O
.	.	.	O	O

LABS	LABS	NN	B-NP	B-protein
:	:	:	O	O
Remarkable	Remarkable	JJ	B-NP	O
labs	lab	NNS	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
include	include	VBP	B-VP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.7	1.7	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
bicarb	bicarb	NN	I-NP	O
of	of	IN	B-PP	O
38	38	CD	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
BNP	BNP	NN	I-NP	B-protein
was	be	VBD	B-VP	O
29	29	CD	B-NP	O
,	,	,	O	O
troponin	troponin	NN	B-NP	O
was	be	VBD	B-VP	O
0.13	0.13	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
crit	crit	NN	I-NP	O
was	be	VBD	B-VP	O
32.4	32.4	CD	B-NP	O
,	,	,	O	O
white	white	JJ	B-NP	O
blood	blood	NN	I-NP	O
count	count	NN	I-NP	O
7.6	7.6	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
platelets	platelet	NNS	B-NP	B-cell_type
267	267	CD	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
differential	differential	JJ	I-NP	O
her	her	PRP$	I-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
93	93	CD	B-NP	O
polys	poly	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
bands	band	NNS	I-NP	O
.	.	.	O	O

Coags	Coag	NNS	B-NP	O
were	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
UA	UA	NN	I-NP	B-DNA
was	be	VBD	B-VP	I-DNA
?	?	.	O	I-DNA
?	?	.	O	I-DNA
__	__	''	O	I-DNA
?	?	.	O	O
?	?	.	O	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
showed	show	VBD	B-VP	I-protein
sinus	sinus	NN	B-NP	I-protein
tachycardia	tachycardia	NN	I-NP	I-protein
106	106	CD	I-NP	I-protein
,	,	,	O	O
some	some	DT	B-NP	O
T-wave	T-wave	JJ	I-NP	O
inversions	inversion	NNS	I-NP	O
in	in	IN	B-PP	O
lead	lead	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
some	some	DT	B-NP	O
flattening	flattening	NN	I-NP	O
in	in	IN	B-PP	O
lead	lead	NN	B-NP	O
5	5	CD	I-NP	O
,	,	,	O	O
but	but	CC	O	O
essentially	essentially	RB	B-ADJP	O
unchanged	unchanged	JJ	I-ADJP	O
from	from	IN	B-PP	O
prior	prior	JJ	B-ADJP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
x-ray	x-ray	NN	I-NP	O
:	:	:	O	O
Portable	Portable	JJ	B-NP	O
AP	AP	NN	I-NP	O
view	view	NN	I-NP	O
with	with	IN	B-PP	O
stable	stable	JJ	B-NP	O
cardiomegaly	cardiomegaly	NN	I-NP	O
,	,	,	O	O
questionable	questionable	JJ	B-ADJP	O
of	of	IN	B-PP	O
lower	low	JJR	B-NP	O
lobe	lobe	NN	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
.	.	.	O	O

ANALYSIS	ANALYSIS	NN	B-NP	O
AND	AND	CC	I-NP	O
PLAN	PLAN	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
59-year-old	59-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
recent	recent	JJ	B-NP	O
COPD	COPD	NN	I-NP	O
and	and	CC	I-NP	O
asthma	asthma	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	O	O
suspected	suspect	VBN	B-NP	O
right	right	JJ	I-NP	O
middle	middle	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
PROBLEM	PROBLEM	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
hypercarbic	hypercarbic	JJ	B-NP	O
,	,	,	I-NP	O
hypoxemic	hypoxemic	JJ	I-NP	O
respiratory	respiratory	JJ	I-NP	O
distress	distress	NN	I-NP	O
,	,	,	O	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
secondary	secondary	JJ	B-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
recurrent	recurrent	JJ	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
obstructive/restrictive	obstructive/restrictive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
volume	volume	NN	B-NP	O
overloaded	overload	VBN	B-VP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
D-Dimer	D-Dimer	NN	I-NP	B-protein
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
restrictive	restrictive	JJ	I-NP	O
lung	lung	NN	I-NP	O
disease	disease	NN	I-NP	O
is	be	VBZ	B-VP	O
most	most	RBS	B-ADJP	O
likely	likely	RB	I-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
body	body	NN	I-NP	O
habitus	habitus	NN	I-NP	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
obesity	obesity	NN	B-NP	O
hyperventilation	hyperventilation	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
obstructive	obstructive	JJ	I-NP	O
disease	disease	NN	I-NP	O
have	have	VBP	B-VP	O
components	component	NNS	B-NP	O
of	of	IN	B-PP	O
asthma	asthma	NN	B-NP	O
since	since	IN	B-NP	O
has	have	VBZ	B-VP	O
responsive	responsive	JJ	B-NP	O
bronchodilation	bronchodilation	NN	I-NP	O
after	after	IN	B-PP	O
beta-agonist	beta-agonist	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
management	management	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
respiratory	respiratory	JJ	I-NP	O
status	status	NN	I-NP	O
involved	involve	VBN	B-VP	O
initially	initially	RB	B-ADVP	O
starting	start	VBG	B-VP	O
on	on	IN	B-PP	O
steroids	steroid	NNS	B-NP	O
,	,	,	O	O
prednisone	prednisone	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
frequent	frequent	JJ	B-NP	O
nebs	neb	NNS	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
continuing	continue	VBG	B-VP	O
her	her	PRP$	B-NP	O
Advair	Advair	NN	I-NP	O
and	and	CC	I-NP	O
Singulair	Singulair	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
planned	plan	VBN	I-VP	O
to	to	TO	I-VP	O
use	use	VB	I-VP	O
BiPAP	BiPAP	NN	B-NP	B-protein
since	since	IN	B-SBAR	O
she	she	PRP	B-NP	O
might	might	MD	B-VP	O
have	have	VB	I-VP	O
sleep	sleep	JJ	B-NP	O
apnea	apnea	NN	I-NP	O
component	component	NN	I-NP	O
despite	despite	IN	B-PP	O
no	no	DT	B-NP	O
objective	objective	JJ	I-NP	O
data	datum	NNS	I-NP	O
supporting	support	VBG	B-VP	O
that	that	DT	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
on	on	IN	B-PP	O
second	second	JJ	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
hospital	hospital	NN	B-NP	O
stay	stay	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
under	under	IN	B-PP	O
increased	increase	VBN	B-NP	O
respiratory	respiratory	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
repeat	repeat	NN	I-NP	O
blood	blood	NN	I-NP	O
gas	gas	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
pH	pH	NN	I-NP	O
of	of	IN	B-PP	O
7.27	7.27	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
PCO2	PCO2	NN	I-NP	B-protein
of	of	IN	B-PP	O
88	88	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
PO2	PO2	NN	I-NP	B-protein
of	of	IN	B-PP	O
82	82	CD	B-NP	O
on	on	IN	B-PP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
O2	O2	NN	B-NP	B-protein
.	.	.	O	O

Since	Since	IN	B-PP	O
clinically	clinically	RB	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
deteriorating	deteriorate	VBG	I-VP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
would	would	MD	B-VP	O
benefit	benefit	VB	I-VP	O
of	of	IN	B-PP	O
intubation	intubation	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
intubated	intubate	VBN	I-VP	O
on	on	IN	B-PP	O
May	May	NNP	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
AC	AC	NN	B-NP	O
mode	mode	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
ventilation	ventilation	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
initially	initially	RB	B-ADVP	O
required	require	VBD	B-VP	O
AC	AC	NN	B-NP	O
since	since	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
maintain	maintain	VB	I-VP	O
good	good	JJ	B-NP	O
total	total	JJ	I-NP	O
volumes	volume	NNS	I-NP	O
on	on	IN	B-PP	O
pressure	pressure	NN	B-NP	O
support	support	NN	I-NP	O
.	.	.	O	O

Multiple	Multiple	JJ	B-NP	O
times	time	NNS	I-NP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
attempted	attempt	VBN	I-VP	O
to	to	TO	I-VP	O
wean	wean	VB	I-VP	O
her	her	PRP	B-NP	O
off	off	IN	B-PP	O
the	the	DT	B-NP	O
ventilator	ventilator	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
developed	develop	VBD	B-VP	O
increased	increase	VBN	I-VP	O
respiratory	respiratory	JJ	B-NP	O
distress	distress	NN	I-NP	O
and	and	CC	O	O
decreased	decrease	VBD	B-VP	O
total	total	JJ	B-NP	O
volume	volume	NN	I-NP	O
with	with	IN	B-PP	O
ventilator	ventilator	NN	B-NP	O
mechanics	mechanic	NNS	I-NP	O
showing	show	VBG	B-VP	O
increased	increase	VBN	B-NP	O
airway	airway	NN	I-NP	O
resistance	resistance	NN	I-NP	O
.	.	.	O	O

Despite	Despite	IN	B-PP	O
frequent	frequent	JJ	B-NP	O
nebs	neb	NNS	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
weaned	wean	VBN	I-VP	O
off	off	IN	B-PP	O
the	the	DT	B-NP	O
ventilator	ventilator	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
January	January	NNP	B-NP	O
,	,	,	O	O
after	after	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
attempts	attempt	NNS	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
would	would	MD	B-VP	O
benefit	benefit	VB	I-VP	O
from	from	IN	B-PP	O
longterm	longterm	JJ	B-NP	O
ventilatory	ventilatory	JJ	I-NP	O
support	support	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
PEG	PEG	NN	I-NP	B-protein
and	and	CC	I-NP	O
tracheostomy	tracheostomy	NN	I-NP	O
placement	placement	NN	I-NP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Rosaro	Rosaro	NNP	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
complications	complication	NNS	I-NP	O
.	.	.	O	O

Since	Since	IN	B-PP	O
January	January	NNP	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
ventilatory	ventilatory	JJ	I-NP	O
settings	setting	NNS	I-NP	O
were	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
to	to	TO	B-PP	O
pressure	pressure	NN	B-NP	O
support	support	NN	I-NP	O
with	with	IN	B-PP	O
peep	peep	NN	B-NP	O
of	of	IN	B-PP	O
5	5	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
pressure	pressure	NN	I-NP	O
support	support	NN	I-NP	O
of	of	IN	B-PP	O
10	10	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
two	two	CD	B-NP	O
recurrent	recurrent	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
increased	increase	VBN	B-NP	O
respiratory	respiratory	JJ	I-NP	O
distress	distress	NN	I-NP	O
when	when	WRB	B-ADVP	O
moved	move	VBN	B-VP	O
in	in	IN	B-PP	O
bed	bed	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
suspected	suspect	VBN	I-VP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
respiratory	respiratory	JJ	I-NP	O
distress	distress	NN	I-NP	O
was	be	VBD	B-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
mechanical	mechanical	JJ	I-NP	O
obstruction	obstruction	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
tracheostomy	tracheostomy	NN	I-NP	O
and	and	CC	O	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
,	,	,	O	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
getting	get	VBG	I-VP	O
a	a	DT	B-NP	O
different	different	JJ	I-NP	O
trach	trach	NN	I-NP	O
recommended	recommend	VBN	B-VP	O
by	by	IN	B-PP	O
surgery	surgery	NN	B-NP	O
which	which	WDT	B-NP	O
will	will	MD	B-VP	O
minimize	minimize	VB	I-VP	O
this	this	DT	B-NP	O
mechanical	mechanical	JJ	I-NP	O
obstruction	obstruction	NN	I-NP	O
.	.	.	O	O

Otherwise	Otherwise	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
currently	currently	RB	B-ADVP	O
on	on	IN	B-PP	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
FIO2	FIO2	NN	B-NP	B-protein
and	and	CC	O	O
a	a	DT	B-NP	O
peep	peep	NN	I-NP	O
of	of	IN	B-PP	O
5	5	CD	B-NP	O
,	,	,	O	O
pressure	pressure	NN	B-NP	O
support	support	NN	I-NP	O
of	of	IN	B-PP	O
12	12	CD	B-NP	O
and	and	CC	I-NP	O
at	at	IN	B-PP	O
those	those	DT	B-NP	O
settings	setting	NNS	I-NP	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
getting	get	VBG	I-VP	O
tidal	tidal	JJ	B-NP	O
volumes	volume	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
range	range	NN	I-NP	O
from	from	IN	B-PP	O
380	380	CD	B-NP	O
to	to	TO	B-PP	O
450	450	CD	B-NP	O
and	and	CC	O	O
O2	O2	NN	B-NP	O
sats	sat	NNS	I-NP	O
between	between	IN	B-PP	O
98	98	CD	B-NP	O
and	and	CC	I-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
suspected	suspect	VBN	I-NP	O
right	right	JJ	I-NP	O
middle	middle	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
fever	fever	NN	I-NP	O
and	and	CC	O	O
increased	increase	VBD	B-VP	O
white	white	JJ	B-NP	O
blood	blood	NN	I-NP	O
count	count	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
would	would	MD	B-VP	O
benefit	benefit	VB	I-VP	O
from	from	IN	B-PP	O
nosocomial	nosocomial	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
coverage	coverage	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
first	first	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
included	include	VBD	B-VP	O
levo	levo	NN	B-NP	O
,	,	,	O	O
clinda	clinda	NN	B-NP	O
.	.	.	O	O

,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
vancomycin	vancomycin	NN	B-NP	O
.	.	.	O	O

Cultures	Culture	NNS	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
sputum	sputum	NN	I-NP	O
and	and	CC	I-NP	O
blood	blood	NN	I-NP	O
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
,	,	,	O	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-cell_line
sputum	sputum	NN	I-NP	I-cell_line
cultures	culture	NNS	I-NP	I-cell_line
just	just	RB	B-ADVP	O
grew	grow	VBD	B-VP	O
oral	oral	JJ	B-NP	O
flora	flora	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
initially	initially	RB	B-ADVP	O
were	be	VBD	B-VP	O
all	all	DT	O	O
negative	negative	JJ	B-ADJP	O
but	but	CC	B-PP	O
on	on	IN	B-PP	O
January	January	NNP	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	O
culture	culture	NN	I-NP	O
for	for	IN	B-PP	O
staph	staph	NN	B-NP	O
.	.	.	O	O

,	,	,	O	O
guaiac	guaiac	JJ	B-NP	O
negative	negative	JJ	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
central	central	JJ	I-NP	B-cell_line
venous	venous	JJ	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
moment	moment	NN	I-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
secondary	secondary	JJ	B-NP	O
infection	infection	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
MSSE	MSSE	NN	B-NP	O
line	line	NN	I-NP	O
infection	infection	NN	I-NP	O
and	and	CC	O	O
all	all	DT	B-NP	O
lines	line	NNS	I-NP	O
were	be	VBD	B-VP	O
pulled	pull	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
for	for	IN	B-PP	O
another	another	DT	B-NP	O
14	14	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
were	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	B-PP	O
ceftaz	ceftaz	NN	B-NP	O
.	.	.	O	O

,	,	,	O	O
azithromycin	azithromycin	NN	B-NP	O
,	,	,	O	O
clindamycin	clindamycin	NN	B-NP	O
and	and	CC	I-NP	O
vancomycin	vancomycin	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
21	21	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
and	and	CC	O	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
had	have	VBD	B-VP	O
finished	finish	VBN	I-VP	O
her	her	PRP$	B-NP	O
ceftaz	ceftaz	NN	I-NP	O
.	.	.	O	O

and	and	CC	O	O
Flagyl	Flagyl	NNP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
14	14	CD	I-NP	O
day	day	NN	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
central	central	JJ	I-NP	B-cell_line
venous	venous	JJ	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
and	and	CC	O	O
since	since	IN	B-PP	O
then	then	RB	B-NP	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
afebrile	afebrile	JJ	B-ADJP	O
and	and	CC	O	O
all	all	DT	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
after	after	IN	B-PP	O
October	October	NNP	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
so	so	RB	O	O
about	about	IN	B-NP	O
10	10	CD	I-NP	O
days	day	NNS	I-NP	O
with	with	IN	B-PP	O
negative	negative	JJ	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
and	and	CC	O	O
sputum	sputum	NN	B-NP	O
cultures	culture	NNS	I-NP	O
.	.	.	O	O

Just	Just	RB	B-ADJP	O
prior	prior	JJ	I-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
IJ	IJ	NN	I-NP	O
line	line	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
removed	remove	VBN	I-VP	O
since	since	IN	B-SBAR	O
she	she	PRP	B-NP	O
just	just	RB	B-ADVP	O
finished	finish	VBD	B-VP	O
her	her	PRP$	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
her	her	PRP$	B-NP	O
peripheral	peripheral	JJ	I-NP	O
A	A	NN	I-NP	O
line	line	NN	I-NP	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
high	high	JJ	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
steroids	steroid	NNS	B-NP	O
,	,	,	O	O
prednisone	prednisone	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
about	about	IN	B-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
couple	couple	NN	I-NP	O
of	of	IN	B-PP	O
attempts	attempt	NNS	B-NP	O
to	to	TO	B-VP	O
decrease	decrease	VB	I-VP	O
the	the	DT	B-NP	O
prednisone	prednisone	NN	I-NP	O
but	but	CC	O	O
responded	respond	VBD	B-VP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
broncho-resistance	broncho-resistance	NN	I-NP	O
on	on	IN	B-PP	O
ventilator	ventilator	NN	B-NP	O
measurements	measurement	NNS	I-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
to	to	TO	I-VP	O
keep	keep	VB	I-VP	O
her	her	PRP	B-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
higher	high	JJR	I-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
week	week	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
slow	slow	JJ	I-NP	O
tapering	tapering	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
with	with	IN	B-PP	O
50	50	CD	B-NP	O
mg	mg	NN	I-NP	O
for	for	IN	B-PP	O
5	5	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
50	50	CD	B-NP	O
mg	mg	NN	I-NP	O
for	for	IN	B-PP	O
another	another	DT	B-NP	O
4	4	CD	I-NP	O
days	day	NNS	I-NP	O
and	and	CC	B-PP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
transition	transition	NN	I-NP	O
point	point	NN	I-NP	O
to	to	TO	B-PP	O
30	30	CD	B-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
getting	get	VBG	I-VP	O
calcium	calcium	NN	B-NP	O
carbonate	carbonate	NN	I-NP	O
and	and	CC	O	O
vitamin	vitamin	NN	B-NP	O
D	D	NN	I-NP	O
for	for	IN	B-PP	O
osteoporosis	osteoporosis	NN	B-NP	O
prevention	prevention	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
diabetes	diabetes	NN	I-NP	O
was	be	VBD	B-VP	O
managed	manage	VBN	I-VP	O
with	with	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
100	100	CD	I-NP	O
units	unit	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
with	with	IN	B-PP	O
Portland	Portland	NNP	B-NP	O
Insulin	Insulin	NNP	I-NP	O
Protocol	Protocol	NNP	I-NP	O
on	on	IN	B-PP	O
initial	initial	JJ	B-NP	O
ICU	ICU	NN	I-NP	O
stay	stay	NN	I-NP	O
transitioned	transitione	VBN	B-VP	O
to	to	TO	B-PP	O
Regular	Regular	JJ	B-NP	O
Insulin	Insulin	NN	I-NP	O
scale	scale	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
needing	need	VBG	I-VP	O
any	any	DT	B-NP	O
extra	extra	JJ	I-NP	O
insulin	insulin	NN	I-NP	O
units	unit	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
A.	A.	NNP	B-NP	O
Ischemia	Ischemia	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
recent	recent	JJ	B-NP	O
workup	workup	NN	I-NP	O
for	for	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
including	include	VBG	B-PP	O
Cath	Cath	NN	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
elevation	elevation	NN	I-NP	O
troponin	troponin	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-VP	O
demand	demand	VB	I-VP	O
ischemia	ischemia	NN	B-NP	O
with	with	IN	B-PP	O
spontaneous	spontaneous	JJ	B-NP	O
resolution	resolution	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
angina	angina	NN	I-NP	O
or	or	CC	O	O
new	new	JJ	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
EKG	EKG	NN	B-NP	B-protein
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

B.	B.	NNP	B-NP	O
Pump	Pump	NNP	I-NP	O
:	:	:	O	O
She	She	NNP	B-NP	O
looked	look	VBD	B-VP	O
slightly	slightly	RB	B-NP	O
volume	volume	NN	I-NP	O
overloaded	overload	VBN	B-VP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
received	receive	VBD	B-VP	O
Lasix	Lasix	NNP	B-NP	O
80	80	CD	I-NP	O
IV	IV	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
diuretic	diuretic	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
might	might	MD	B-VP	O
need	need	VB	I-VP	O
,	,	,	O	O
once	once	RB	B-VP	O
discharged	discharge	VBN	I-VP	O
,	,	,	O	O
a	a	DT	B-NP	O
standing	standing	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
to	to	TO	B-VP	O
maintain	maintain	VB	I-VP	O
her	her	PRP$	B-NP	O
I	I	NN	I-NP	O
's	's	POS	B-NP	O
and	and	CC	O	O
O	O	NNP	B-NP	O
's	's	POS	B-NP	O
goal	goal	NN	I-NP	O
even	even	RB	B-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
off	off	IN	B-PP	O
the	the	DT	B-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	O
stay	stay	NN	I-NP	O
ranged	range	VBD	B-VP	O
between	between	IN	B-PP	O
112	112	CD	B-NP	B-DNA
and	and	CC	I-NP	I-DNA
130	130	CD	I-NP	I-DNA
.	.	.	O	O

We	We	PRP	B-NP	O
plan	plan	VBP	B-VP	O
to	to	TO	I-VP	O
restart	restart	VB	I-VP	O
her	her	PRP	B-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
small-dose	small-dose	JJ	I-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
objective	objective	NN	I-NP	O
of	of	IN	B-PP	O
better	good	JJR	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
control	control	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
renal	renal	JJ	B-NP	O
protection	protection	NN	I-NP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
diabetes	diabetes	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
will	will	MD	B-VP	O
not	not	RB	I-VP	O
restart	restart	VB	I-VP	O
Isordil	Isordil	NN	B-NP	O
since	since	IN	B-SBAR	O
patient	patient	NN	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Psych	Psych	NN	B-NP	O
:	:	:	O	O
We	We	PRP	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
home	home	NN	B-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
Trileptal	Trileptal	NNP	B-NP	O
,	,	,	O	O
Depakote	Depakote	NNP	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Risperdal	Risperdal	NNP	B-NP	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
Her	Her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
has	have	VBZ	B-VP	O
remained	remain	VBN	I-VP	O
stable	stable	JJ	B-ADJP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

Since	Since	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
getting	get	VBG	I-VP	O
multiple	multiple	JJ	B-NP	O
blood	blood	NN	I-NP	O
draws	draw	NNS	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
received	receive	VBD	B-VP	O
about	about	RB	B-NP	O
2	2	CD	I-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
all	all	DT	B-NP	O
her	her	PRP$	I-NP	O
workup	workup	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
anemia	anemia	NN	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
including	include	VBG	B-PP	O
vitamin	vitamin	NN	B-NP	B-protein
B12	B12	NN	I-NP	I-protein
,	,	,	O	O
including	include	VBG	B-PP	O
iron	iron	NN	B-NP	O
studies	study	NNS	I-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
heme	heme	NN	I-NP	B-protein
?	?	.	O	O

__	__	LS	B-LST	O
?	?	.	O	O

panel	panel	NN	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Musculoskeletal	Musculoskeletal	JJ	B-ADJP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
infiltrative	infiltrative	NN	I-NP	O
?	?	.	O	O

___	___	LS	B-LST	O
?	?	.	O	O

on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
arm	arm	NN	I-NP	O
around	around	IN	B-PP	O
her	her	PRP$	B-NP	O
peripheral	peripheral	JJ	I-NP	O
IV	IV	CD	I-NP	O
access	access	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
infiltration	infiltration	NN	I-NP	O
lead	lead	VBP	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
ulcer	ulcer	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
managed	manage	VBN	I-VP	O
by	by	IN	B-PP	O
Plastics	Plastic	NNS	B-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
recommended	recommend	VBD	B-VP	O
only	only	RB	B-VP	O
b.i.d.	b.i.d.	RB	I-VP	O
dressing	dress	VBG	I-VP	O
changes	change	NNS	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
evident	evident	JJ	B-NP	O
infection	infection	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
site	site	NN	I-NP	O
and	and	CC	O	O
healing	heal	VBG	B-VP	O
since	since	IN	B-PP	O
that	that	DT	B-NP	O
event	event	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
quite	quite	RB	B-ADJP	O
good	good	JJ	I-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
are	be	VBP	B-VP	O
some	some	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
granulation	granulation	NN	B-NP	O
tissue	tissue	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ulcer	ulcer	NN	I-NP	O
base	base	NN	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
erythema	erythema	NN	I-NP	O
or	or	CC	I-NP	O
pus	pus	NN	I-NP	O
around	around	IN	B-PP	O
it	it	PRP	B-NP	O
.	.	.	O	O

Physical	Physical	JJ	B-NP	O
Therapy	Therapy	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
case	case	NN	I-NP	O
and	and	CC	O	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
doing	do	VBG	I-VP	O
tremendous	tremendous	JJ	B-NP	O
work	work	NN	I-NP	O
in	in	IN	B-PP	O
putting	put	VBG	B-VP	O
her	her	PRP	B-NP	O
sitting	sit	VBG	B-VP	O
upright	upright	RB	B-ADVP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
gaining	gain	VBG	B-VP	O
increased	increase	VBN	B-NP	O
strength	strength	NN	I-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
extremity	extremity	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
still	still	RB	B-ADVP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
raise	raise	VB	I-VP	O
her	her	PRP$	B-NP	O
arm	arm	NN	I-NP	O
against	against	IN	B-PP	O
gravity	gravity	NN	B-NP	O
but	but	CC	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
2/5	2/5	CD	B-NP	O
muscle	muscle	NN	I-NP	O
strength	strength	NN	I-NP	O
throughout	throughout	IN	B-ADVP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
likely	likely	RB	I-VP	O
need	need	VB	I-VP	O
intensive	intensive	JJ	B-NP	O
rehab	rehab	NN	I-NP	O
once	once	IN	B-SBAR	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
metabolic	metabolic	JJ	I-NP	O
test	test	NN	I-NP	O
performed	perform	VBN	B-VP	O
which	which	WDT	B-NP	O
yielded	yield	VBD	B-VP	O
a	a	DT	B-NP	O
measure	measure	NN	I-NP	O
resting	rest	VBG	B-VP	O
energy	energy	NN	B-NP	O
expender	expender	NN	I-NP	O
of	of	IN	B-PP	O
2121	2121	CD	B-NP	O
kilocalories	kilocalorie	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
predicted	predict	VBN	I-NP	O
basal	basal	JJ	I-NP	O
metabolic	metabolic	JJ	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
1771	1771	CD	B-NP	O
kilocalories	kilocalorie	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Those	Those	DT	B-NP	O
results	result	NNS	I-NP	O
yielded	yield	VBD	B-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
tube	tube	NN	I-NP	O
feedings	feeding	NNS	I-NP	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
consisted	consist	VBN	I-VP	O
of	of	IN	B-PP	O
Osmolite	Osmolite	NN	B-NP	B-protein
1.2	1.2	CD	I-NP	I-protein
at	at	IN	B-PP	O
70	70	CD	B-NP	O
cc	cc	NN	I-NP	O
an	an	DT	B-NP	O
hour	hour	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
0-8247167	0-8247167	CD	B-NP	O
MCS	MCS	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
HARGITT	HARGITT	NNP	B-NP	O
,	,	,	O	O
ARTHUR	ARTHUR	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
OAKDEN	OAKDEN	NNP	B-NP	O
,	,	,	O	O
JEFFRY	JEFFRY	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
3474077	3474077	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
3/8/05	3/8/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
3/8/05	3/8/05	CD	B-NP	O

